Ludovic Helfgott/LinkedIn
Mar 11, 2026, 14:54
Ludovic Helfgott: Grateful for Generosity in Supporting Patients with Hemophilia and Hemoglobinopathies
Ludovic Helfgott, Executive Vice President, Product and Portfolio Strategy at Novo Nordisk, shared a post on LinkedIn:
“One of the most gratifying things in the life of a Chairman of a not-for-profit organization is to take money directly from the pockets of your great colleagues and friends …for a good cause …and still see them smile afterwards.
Thanks to Maziar Mike Doustdar, Martin Holst Lange, Kasper Bødker Mejlvang, Habib Bennaceur (and many others) for your wonderful generosity in helping patients with hemophilia, hemoglobinopathies or diabetes around the world.”

Stay updated with Hemostasis Today.
-
Jul 26, 2026, 16:26Novi Yanti Sari: When MPNs Affect the Heart
-
Jul 26, 2026, 16:21Beyond Drugs: Can Museums Become a Medical Prescription?
-
Jul 26, 2026, 14:45Sarah Giorgia Grazia Giannone: An Exciting Chapter in Gene Therapy Research
-
Jul 26, 2026, 14:21Javed Anees: Cerebral Collateral Circulation in Acute Ischemic Stroke
-
Jul 26, 2026, 14:11André Picard։ Canadian Blood Supplies Drop Sharply, Urgent Donor Appeal Issued
-
Jul 26, 2026, 13:54Lorenzo Scalia: New Review Highlights Anticoagulant Strategies for Elderly Patients With Atrial Fibrillation
-
Jul 26, 2026, 13:32Ahmed Kotb: A Practical Guide to Von Willebrand Disease
-
Jul 26, 2026, 12:42Emmanuel J Favaloro: Celebrating Excellence in Scientific Peer Review
-
Jul 26, 2026, 12:20Advancing Sickle Cell Care Through Advocacy – American Society of Hematology